Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 50% Off
/Free Sign Up
 0
Nederlandse versie beschikbaar
Wilt u liever naar Investing.com's Nederlandse editie?
Nee, bedanktBreng me erheen
🧠 Smart money is quietly buying these undervalued gems
See Undervalued Stocks
Close

Novartis AG ADR (NVS)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Novartis ADR's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
152.06 -1.32    -0.86%
15:59:59 - Closed. Currency in USD
After Hours
151.00
-1.08
-0.71%
16:16:20 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,089,661
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 150.87 - 154.10
Novartis ADR 152.06 -1.32 -0.86%

Novartis ADR Option Chain

 
View the NVS options chain and compare options of Novartis ADR stock. Analyze the various options available, including call options (the right to buy) and put options (the right to sell), along with their strike prices and expiration dates. Evaluate the prices and premiums associated with these options to make informed decisions about your trading strategies. Assess the Open Positions chart to find information about the distribution of open options contracts for NVS stock at various strike prices and expiration dates. Gain insights into the options market sentiment and the potential trading activity surrounding the Novartis ADR stock.
Expiration Date:
Show:
Strike Price:
QuotesAnalysis
Nov 28, 2025 08:08PM GMT

Calls

Puts

Last Chg. Bid Ask Vol Strike Last Chg. Bid Ask Vol
66.5 0% 78.5 82 0 30.00 0 0% 0 0 0
63.15 0% 74 76.8 0 35.00 0 0% 0 0 0
71.1 0% 69.8 72.6 1 40.00 0 0% 0 0 0
0 0% 85.2 88.1 0 65.00 0 0% 0 2.15 0
0 0% 80.3 83.1 0 70.00 0 0% 0 2.15 0
0 0% 75.7 77.9 0 75.00 0 0% 0 2.15 0
130.4
 Price @ Nov 28, 2025 08:08PM GMT
0.25 -71.59% 0.25 0.55 5 155.00 2 0% 2.8 4.3 0
0.1 -50% 0 0.2 2 160.00 8.25 27.31% 7.5 8.6 2
0.06 0% 0 0.2 0 165.00 13.2 0% 12.3 13.2 2

Open Positions

 Calls
 Puts
© 2016 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NVS Comments

Write your thoughts about Novartis AG ADR
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jonah Garber
Jonah Garber Aug 03, 2022 9:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
NVS reported solid results for Q1 that included a 10% jump in sales for its top-selling Cosentyx psoriatic arthritis drug. With a diverse portfolio of pharmaceuticals and strong momentum in a down market, NVS is worth a look for many reasons
Reply
0 1
Report
Jonathan Sanders
Jonathan Sanders Aug 03, 2022 9:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Thanks in part to strong performance, this is one of a few stocks that has posted positive gains in 2022 despite headwinds elsewhere in the market.
Reply
1 0
Report
Zoran Labus
Zoran Labus Mar 25, 2021 11:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
Reply
0 1
Report
Pankaj Negi
Pankaj Negi Jan 20, 2021 1:09PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
buy
Reply
1 0
Report
Pete Pete
Pete Pete Sep 30, 2020 12:02PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
A
Reply
0 0
Report
stats con chris
stats con chris Jun 17, 2020 12:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
just to know. I'm lost.this is the company that bought the medicines company?
Reply
0 0
Report
Kristof Mouton
Stoffel Sep 17, 2019 4:42PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
before investing in @novartis, read #teampia (twitter).
Reply
0 0
Report
Kast Kast
Kbkb Feb 07, 2019 2:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
154952291883003.jpg
sell 89 expecting 80 timeframe 5 days
Reply
1 1
Report
Robin Hood
Robin Hood Sep 28, 2018 7:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Long ENDOCYTE... I work in the field
Reply
0 0
Report
Episcopolian OptionTrader
Episcopolian1 Jul 19, 2017 11:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$NVS: Novartis AG Looking at All Options Including IPO for Alcon Unit.. This is HUGE catalyst for $NVS share holders!!!!!
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Apple
Continue with Google
or
Sign up with Email